Additionally, beta-hydroxybutyrate (BHB), a ketone body produced during fasting or ketogenic diets, reduces AD pathology through NLRP3 inhibition, suggesting a protective effect against neuroinflammation [63,64]. The gene discussed is NLRP3; the disease is Alzheimer disease.